| Size | Price | Stock | Qty |
|---|---|---|---|
| 10mg |
|
||
| 50mg |
|
||
| 100mg |
|
||
| Other Sizes |
| Targets |
The specific molecular targets of CL4H6 are not reported in the available literature. As the compound is listed as "removed," it is likely that it is no longer commercially available or actively researched. Without published studies or supplier information, the target profile of this compound cannot be determined.
|
|---|---|
| ln Vitro |
In vitro activity data for CL4H6 are not available in the literature. As a compound with limited public information and a "removed" status, no specific in vitro studies have been reported. The compound's biological activity, if any, has not been characterized.
|
| ln Vivo |
In vivo data for CL4H6 are not available. The compound is not described in the literature as having been tested in animal models. Its "removed" status suggests that it is not currently being actively studied or developed.
|
| Enzyme Assay |
No experimental protocols for CL4H6 are available in the literature. As a compound with limited information and a "removed" status, standard assays have not been reported. If the compound were to be studied, standard protocols for the relevant biological target would apply.
|
| Cell Assay |
No cellular assay protocols for CL4H6 are reported. The compound is not described in cell-based studies. Its "removed" status indicates that it is not currently being used in cellular research applications.
|
| Animal Protocol |
No animal study protocols for CL4H6 are available. The compound has not been reported in in vivo studies. Its "removed" status suggests it is not being evaluated in animal models.
|
| ADME/Pharmacokinetics |
Pharmacokinetic data for CL4H6 are not reported. The compound's physicochemical properties, including molecular weight and solubility, are not publicly available. Its "removed" status indicates limited characterization.
|
| Toxicity/Toxicokinetics |
Toxicological data for CL4H6 are not reported. As a compound with limited information and a "removed" status, safety data are not available. Standard safety precautions should be taken when handling any chemical compound.
|
| References |
|
| Additional Infomation |
CL4H6 (CAS 2256087-35-9) is a chemical compound listed as "removed," indicating it may no longer be commercially available or actively researched. No biological activity, target information, or research applications are reported in the available literature. For research use only if available.
|
| Molecular Formula |
C59H113NO5
|
|---|---|
| Molecular Weight |
916.532239675522
|
| Exact Mass |
915.861
|
| CAS # |
2256087-35-9
|
| Related CAS # |
2256087-35-9;
|
| PubChem CID |
146593563
|
| Appearance |
Viscous Liquid
|
| LogP |
21
|
| Hydrogen Bond Donor Count |
1
|
| Hydrogen Bond Acceptor Count |
6
|
| Rotatable Bond Count |
55
|
| Heavy Atom Count |
65
|
| Complexity |
970
|
| Defined Atom Stereocenter Count |
0
|
| SMILES |
CCCCCCCC/C=C\CCCCCCCC(=O)OCCCCCCC(O)(CCCCN(CCC)CCC)CCCCCCOC(=O)CCCCCCC/C=C\CCCCCCCC
|
| InChi Key |
ZFFZMGJMZGAGMF-SXAUZNKPSA-N
|
| InChi Code |
InChI=1S/C59H113NO5/c1-5-9-11-13-15-17-19-21-23-25-27-29-31-33-39-47-57(61)64-55-45-37-35-41-49-59(63,51-43-44-54-60(52-7-3)53-8-4)50-42-36-38-46-56-65-58(62)48-40-34-32-30-28-26-24-22-20-18-16-14-12-10-6-2/h21-24,63H,5-20,25-56H2,1-4H3/b23-21-,24-22-
|
| Chemical Name |
[7-[4-(dipropylamino)butyl]-7-hydroxy-13-[(Z)-octadec-9-enoyl]oxytridecyl] (Z)-octadec-9-enoate
|
| Synonyms |
7-(4-(dipropylamino)butyl)-7-hydroxytridecane-1,13-diyl dioleate;CL4H6; CL-4H6; CL 4H6;
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
DMSO: ~100 mg/mL (~109.1 mM; with ultrasonication)
|
|---|---|
| Solubility (In Vivo) |
Solubility in Formulation 1: 2.5 mg/mL (2.73 mM) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), Suspended solution; with ultrasonication.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of DMSO stock solution (25.0 mg/mL) to 900 μL of 20% SBE-β-CD saline and mix well. Preparation of 20% SBE-β-CD in Saline (4°C，1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (2.73 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), Clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of DMSO stock solution (25.0 mg/mL) to 900 μL of corn oil and mix well. (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 1.0911 mL | 5.4554 mL | 10.9107 mL | |
| 5 mM | 0.2182 mL | 1.0911 mL | 2.1821 mL | |
| 10 mM | 0.1091 mL | 0.5455 mL | 1.0911 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
